Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations

Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations

Abstract Background Recent studies have demonstrated that patients with stage IB-IIIA non-small cell lung cancer (NSCLC) harboring EGFR mutations (EGFRm) can significantly benefit from adjuvant therapy with EGFR-TKIs. Nevertheless, there remains controversial in clinical practice about the use of EG...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunyi Li, Zhihui Yang, Fang Wu, Qingchun Liang, James G. Herman, Malcolm V. Brock, Wenliang Liu, Fenglei Yu, Xue He, Chen Chen
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Clinical Epigenetics
Subjects:
Non-small cell lung cancer
Recurrence
DNA methylation
EGFR mutation
Risk factor
Online Access:https://doi.org/10.1186/s13148-025-01899-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13148-025-01899-9

Similar Items